Research: Oxford University close to breakthrough with malaria vaccine
Share article:
Share article:

Research: Oxford University close to breakthrough with malaria vaccine

©Jim Gethany/CDC/Wikimedia

Oxford University, one of the creators of the AstraZeneca vaccine against Covid-19, has reported a historic breakthrough in the development of a vaccine against malaria, one of the most deadly diseases on earth.

The university researchers carried out what is admittedly a small clinical study, involving 450 children aged five to 17 months in Burkina Faso.

Their candidate vaccine, named R21/Matrix-M, achieved a rate of efficacy of 77%, which is considered “highly effective” with the vaccine being well tolerated with a favourable safety profile.

Malaria, spread by the mosquito, has been considered one of the plagues of the modern world, long before Covid-19 made its appearance. Malaria is endemic in many parts of the world, including regions of Africa, where the mosquitoes breed in patches of standing water, just as their cousins do here in your back garden.

But in those regions, the sting of the mosquito can be deadly, with 229 million cases of infection registered in 2019, leading to 400,000 deaths, according to the World Health Organisation (WHO), including 270,000 children.

For that reason, the hunt for a vaccine has been going on for almost a century. One candidate, from GlaxoSmithKline, has achieved only 39% efficacy, and 29% among small children. Clinical trials are being carried out in Kenya, Ghana and Malawi.
The Oxford candidate is the first to achieve the WHO’s target of 75% efficacy, and while the research group is small, new trials in four countries will now begin involving 4,800 children.

Trials involving children are important because the group makes up more than half of all malaria deaths. Children are as susceptible to being infected as adults, but adults who were previously infected have a native immunity, and while they are still able to suffer the symptoms of the disease, they are less likely to die.

That immune protection is something a controlled vaccine could provide, making sure that the first infection, as it were, was administered with a vaccine, thus providing life-long protection.

What we’re hoping to do is take that 400,000 down to tens of thousands in the next five years, which would be absolutely fantastic,” said Professor Adrian Hill, director of the Jenner Institute, where the Oxford/AstraZeneca Covid vaccine was invented. The vaccine has the potential to cut the death toll dramatically, he told the Guardian.

The institute hopes its partner, the Serum Institute of India, will be able to go ahead to produce 200 million doses of the vaccine a year.

Among the steps on the horizon: an application to the WHO for approval for use in Africa, and an application for a scientific opinion from the regulatory authorities in the UK and EU.

They did Covid in months – why shouldn’t they do malaria in a similar length of time as the health problem is on an even greater scale in Africa?” Prof Hill said.

Malaria killed at least four times as many more people in Africa last year as Covid did,” he told New Scientist. “Nobody for a moment questioned whether Covid should have an emergency use review and authorisation in Africa – of course it did, very quickly. So why shouldn’t a disease that firstly kills children rather than older people, and certainly killed an awful lot more, be prioritised for emergency use authorisation in Africa?”

Alan Hope
The Brussels Times

Latest news

Angèle releases new single: ‘Bruxelles je t’aime’
Belgian singer Angèle has unveiled her latest song ahead of the release of her new album, due later this year. 'Bruxelles je t'aime' (Brussels I ...
23 million chickens and 1.7 million pigs: Climate experts call for livestock cut
Flander's livestock needs to be drastically cut to save the climate and reach the emission reduction targets, according to the latest advice from the ...
Vaccination uptake surges in Wallonia following CST announcement
The number of people getting vaccinated against the coronavirus increased fourfold in Wallonia after it was announced that the Covid Safe Ticket ...
Guilty by association
BRUSSELS BEHIND THE SCENES Weekly analysis and untold stories With SAM MORGAN Other Brussels behind the scenes stories: Brussels' bid to make ...
Health minister supports use of Covid Safe Ticket in workplace
As the use of the Covid Safe Ticket (CST) has been expanded in Brussels and is set to in Wallonia, federal health minister Frank Vandenbroucke has ...
Maggots show Conings may have lived longer following disappearance
Former army soldier Jürgen Conings, whose disappearance in mid-May resulted in a month-long manhunt, may have been alive for longer than has been ...
Pandora Papers: European Parliament describes UK and US as global hubs for money laundering and tax evasion
The European Parliament adopted on Thursday a resolution taking the European Commission to task for not doing enough to combat money laundering, tax ...
Museum Night Fever returns to Brussels on Saturday night
After a break last year, Museum Night Fever 2021 is back again with free visits to 29 museums hosting performances, music and other events. The ...
More than 100 people hospitalised with coronavirus per day
More than 100 people are being hospitalised per day in Belgium as a result of the coronavirus, as the rise in new Covid-19 infections continues its ...
Digital well-being: being healthy in a hyperconnected world
There was hardly any doubt about the direction that digital innovation was moving in, but whilst the pandemic restricted human contact and slowed ...
Belgian Health Minister wants pharmacists to administer vaccines
Federal Health Minister Frank Vandenbroucke has said he wants to change Belgium's law to allow pharmacists to administer Covid-19 vaccines against, ...
Ruined photos from flood victims restored for free
Much of what victims of this summer’s deadly flooding lost is irreplaceable, but when it comes to photographs that were ruined, a Brussels company is ...